Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica M Rusert

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer Cell|December 10, 2014
SnapShot: MedulloblastomaJessica M Rusert, Xiaochong Wu, Charles G Eberhart, et al.
Journal of Proteome Research|August 17, 2022
Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived XenograftsKristin L Leskoske, Krystine Garcia-Mansfield, Ritin Sharma, et al.
Biomaterials|December 10, 2021
Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo culturesMichael Hu, Xin Yi Lei, Jon D Larson, et al.
Oncotarget|May 14, 2015
Proteomic profiling of high risk medulloblastoma reveals functional biologyJerome A Staal, Ling San Lau, Huizhen Zhang, et al.
Nature Communications|January 20, 2019
Lsd1 as a therapeutic target in Gfi1-activated medulloblastomaCatherine Lee, Vasilisa A Rudneva, Serap Erkek, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2013
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemiaQingfei Jiang, Leslie A Crews, Christian L Barrett, et al.
Science Signaling|September 13, 2018
Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastomaTeresa Purzner, James Purzner, Taylor Buckstaff, et al.
Cancer Research|October 11, 2022
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of MedulloblastomaAnna Borgenvik, Karl O Holmberg, Sara Bolin, et al.
Cancer Research|October 13, 2020
Functional Precision Medicine Identifies New Therapeutic Candidates for MedulloblastomaJessica M Rusert, Edwin F Juarez, Sebastian Brabetz, et al.
Nature Neuroscience|May 20, 2020
Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastomaAlexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Cell|December 10, 2014
SnapShot: MedulloblastomaJessica M Rusert, Xiaochong Wu, Charles G Eberhart, et al.
Journal of Proteome Research|August 17, 2022
Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived XenograftsKristin L Leskoske, Krystine Garcia-Mansfield, Ritin Sharma, et al.
Biomaterials|December 10, 2021
Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo culturesMichael Hu, Xin Yi Lei, Jon D Larson, et al.
Oncotarget|May 14, 2015
Proteomic profiling of high risk medulloblastoma reveals functional biologyJerome A Staal, Ling San Lau, Huizhen Zhang, et al.
Nature Communications|January 20, 2019
Lsd1 as a therapeutic target in Gfi1-activated medulloblastomaCatherine Lee, Vasilisa A Rudneva, Serap Erkek, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2013
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemiaQingfei Jiang, Leslie A Crews, Christian L Barrett, et al.
Science Signaling|September 13, 2018
Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastomaTeresa Purzner, James Purzner, Taylor Buckstaff, et al.
Cancer Research|October 11, 2022
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of MedulloblastomaAnna Borgenvik, Karl O Holmberg, Sara Bolin, et al.
Cancer Research|October 13, 2020
Functional Precision Medicine Identifies New Therapeutic Candidates for MedulloblastomaJessica M Rusert, Edwin F Juarez, Sebastian Brabetz, et al.
Nature Neuroscience|May 20, 2020
Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastomaAlexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, et al.
Pageof 2